{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:34:56Z","timestamp":1789198496182,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["CA57"],"award-info":[{"award-number":["CA57"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fluoroquinolone resistance in\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    typically arises through site-specific mutations and overexpression of efflux pumps. In this study, we investigated the dynamics of different resistance mechanisms in\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    populations that have evolved under fluoroquinolone pressure, as well as the interactions between these mechanisms in evolutionary trajectories. Bacteria of strain ATCC27853 were selected under different concentrations of ciprofloxacin and levofloxacin for six parallel lineages, followed by amplification of four target genes in the quinolone-resistance determining region (QRDR) and Sanger sequencing to identify the mutations. The expression of four efflux pump proteins was evaluated by real-time polymerase chain reaction using the relative quantitation method, with the ATCC27853 strain used as a control. We found that ciprofloxacin killed\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    sooner than did levofloxacin. Further, we identified five different mutations in three subunits of QRDRs, with\n                    <jats:italic>gyrA<\/jats:italic>\n                    as the main mutated gene associated with conferring fluoroquinolone resistance. Additionally, we found a larger number of mutations appearing at 2\u2009mg\/L and 4\u2009mg\/L of ciprofloxacin and levofloxacin, respectively. Moreover, we identified the main efflux pump being expressed as MexCD-OprJ, with initial overexpression observed at 0.25\u2009mg\/L and 0.5\u2009mg\/L of ciprofloxacin and levofloxacin, respectively. These results demonstrated\n                    <jats:italic>gyrA<\/jats:italic>\n                    <jats:sup>83<\/jats:sup>\n                    mutation and MexCD-OprJ overexpression as the primary mechanism conferring ciprofloxacin and levofloxacin resistance in\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    . In addition, we also show that ciprofloxacin exhibited a stronger ability to kill the bacteria while potentially rendering it more susceptible to resistance.\n                  <\/jats:p>","DOI":"10.1186\/s13756-020-00793-8","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T05:03:02Z","timestamp":1596603782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa"],"prefix":"10.1186","volume":"9","author":[{"given":"Lei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-6250","authenticated-orcid":false,"given":"Xiaojing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"793_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12890-016-0339-5","volume":"16","author":"AY Bhagirath","year":"2016","unstructured":"Bhagirath AY, Li Y, Somayajula D, Dadashi M, Badr S, Duan K. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. BMC Pulm Med. 2016;16:174.","journal-title":"BMC Pulm Med"},{"key":"793_CR2","first-page":"w13509","volume":"142","author":"K Engler","year":"2012","unstructured":"Engler K, Muhlemann K, Garzoni C, Pfahler H, Geiser T, von Garnier C. Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients. Swiss Med Wkly. 2012;142:w13509.","journal-title":"Swiss Med Wkly"},{"key":"793_CR3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1128\/AAC.01581-12","volume":"57","author":"S Bruchmann","year":"2013","unstructured":"Bruchmann S, Dotsch A, Nouri B, Chaberny IF, Haussler S. Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance. Antimicrob Agents Chemother. 2013;57:1361\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/jac\/dkv134","volume":"70","author":"G Zhang","year":"2015","unstructured":"Zhang G, Wang C, Sui Z, Feng J. Insights into the evolutionary trajectories of fluoroquinolone resistance in Streptococcus pneumoniae. J Antimicrob Chemother. 2015;70:2499\u2013506.","journal-title":"J Antimicrob Chemother"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.1128\/AAC.00101-11","volume":"55","author":"C Llanes","year":"2011","unstructured":"Llanes C, Kohler T, Patry I, Dehecq B, van Delden C, Plesiat P. Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin. Antimicrob Agents Chemother. 2011;55:5676\u201384.","journal-title":"Antimicrob Agents Chemother"},{"key":"793_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.drup.2014.02.002","volume":"16","author":"G Jansen","year":"2013","unstructured":"Jansen G, Barbosa C, Schulenburg H. Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance. Drug Resist Updat. 2013;16:96\u2013107.","journal-title":"Drug Resist Updat"},{"key":"793_CR7","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1126\/science.1208747","volume":"333","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Lambert G, Liao D, Kim H, Robin K, Tung CK, Pourmand N, Austin RH. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science. 2011;333:1764\u20137.","journal-title":"Science"},{"key":"793_CR8","doi-asserted-by":"publisher","unstructured":"Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014;2(5):10.1128\/microbiolspec.PLAS-0006-2013. https:\/\/doi.org\/10.1128\/microbiolspec.PLAS-0006-2013.","DOI":"10.1128\/microbiolspec.PLAS-0006-2013"},{"key":"793_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijantimicag.2008.03.012","volume":"32","author":"A Turkmani","year":"2008","unstructured":"Turkmani A, Psaroulaki A, Christidou A, Chochlakis D, Tabaa D, Tselentis Y. In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA. Int J Antimicrob Agents. 2008;32:227\u201332.","journal-title":"Int J Antimicrob Agents"},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrmicro1872","volume":"6","author":"M Achtman","year":"2008","unstructured":"Achtman M, Wagner M. Microbial diversity and the genetic nature of microbial species. Nat Rev Microbiol. 2008;6:431\u201340.","journal-title":"Nat Rev Microbiol"},{"key":"793_CR11","first-page":"1386","volume":"8","author":"X Yang","year":"2015","unstructured":"Yang X, Xing B, Liang C, Ye Z, Zhang Y. Prevalence and fluoroquinolone resistance of pseudomonas aeruginosa in a hospital of South China. Int J Clin Exp Med. 2015;8:1386\u201390.","journal-title":"Int J Clin Exp Med"},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/mdr.2011.0019","volume":"18","author":"MR Pasca","year":"2012","unstructured":"Pasca MR, Dalla Valle C, De Jesus Lopes Ribeiro AL, Buroni S, Papaleo MC, Bazzini S, Udine C, Incandela ML, Daffara S, Fani R, et al. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. Microb Drug Resist. 2012;18:23\u201332.","journal-title":"Microb Drug Resist"},{"key":"793_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1128\/AEM.03280-15","volume":"82","author":"D Khalil","year":"2016","unstructured":"Khalil D, Becker CAM, Tardy F. Alterations in the quinolone resistance-determining regions and Fluoroquinolone resistance in clinical isolates and laboratory-derived mutants of mycoplasma bovis: not all genotypes may be equal. Appl Environ Microbiol. 2016;82:1060\u20138.","journal-title":"Appl Environ Microbiol"},{"key":"793_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijantimicag.2004.11.012","volume":"25","author":"JK Lee","year":"2005","unstructured":"Lee JK, Lee YS, Park YK, Kim BS. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents. 2005;25:290\u20135.","journal-title":"Int J Antimicrob Agents"},{"key":"793_CR15","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1007\/s11274-014-1692-2","volume":"30","author":"HA Terzi","year":"2014","unstructured":"Terzi HA, Kulah C, Ciftci IH. The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa. World J Microbiol Biotechnol. 2014;30:2681\u20137.","journal-title":"World J Microbiol Biotechnol"},{"key":"793_CR16","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ja.2015.34","volume":"68","author":"K Shigemura","year":"2015","unstructured":"Shigemura K, Osawa K, Kato A, Tokimatsu I, Arakawa S, Shirakawa T, Fujisawa M. Association of overexpression of efflux pump genes with antibiotic resistance in Pseudomonas aeruginosa strains clinically isolated from urinary tract infection patients. J Antibiotics. 2015;68:568\u201372.","journal-title":"J Antibiotics"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-020-00793-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T19:09:40Z","timestamp":1628104180000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00793-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00793-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-19662\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-19662\/v1","asserted-by":"object"}]},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}